≡

Eukaryotic Insulin Like Growth Factor Binding Protein 2 (IGFBP2)

IBP2; IGF-BP53

  • Product No.EPA053Mu61
  • Organism SpeciesMus musculus (Mouse) Same name, Different species.
  • SourceEukaryotic expression
  • Host293F cell
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted
  • Predicted Molecular Mass56.8kDa
  • Accurate Molecular Mass70kDa(Analysis of differences refer to the manual)
  • Residues & TagsAla34~Gln305 with N-terminal His Tag and C-terminal Fc Region of Human IgG1
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Point7.3
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 248  US$ 620  US$ 1240  US$ 3720  US$ 9300 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
British journal of cancer A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. pubmed:28664912
Experimental and Therapeutic Medicine Identification and validation of differentially expressed proteins in serum of CSU patients with different duration of wheals using an iTRAQ labeling, 2D‑LC‑MS/MS Doi: 10.3892/etm.2018.6818
Nutrition and Cancer Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer Pubmed: 32286106
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
APA053Mu61 Active Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Cell culture; Activity Assays.
RPA053Mu01 Recombinant Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Positive Control; Immunogen; SDS-PAGE; WB.
APA053Mu01 Active Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Cell culture; Activity Assays.
EPA053Mu61 Eukaryotic Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA053Mu05 Recombinant Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA053Mu02 Recombinant Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA053Mu03 Recombinant Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA053Mu04 Recombinant Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Positive Control; Immunogen; SDS-PAGE; WB.
PAA053Mu01 Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2) WB; IHC; ICC; IP.
PAA053Mu06 Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2) WB; IHC; ICC; IP.
LAA053Mu71 Biotin-Linked Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2) WB; IHC; ICC.
SEA053Mu ELISA Kit for Insulin Like Growth Factor Binding Protein 2 (IGFBP2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA053Mu Multiplex Assay Kit for Insulin Like Growth Factor Binding Protein 2 (IGFBP2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.